Brief: TRACON Pharmaceuticals Inc Says On June 2 ICC Informed Co Of Extended Time Limit For Tribunal To Render Final Decision In Ongoing Arbitration With I-Mab Until Sept 30
June 15 (Reuters) - TRACON Pharmaceuticals Inc TCON.O :
* TRACON PHARMA - ON JUNE 2 ICC INFORMED CO OF EXTENDED TIME
LIMIT
FOR TRIBUNAL TO RENDER FINAL DECISION IN ONGOING ARBITRATION
WITH I-MAB UNTIL SEPT 30
* TRACON PHARMA- TRIBUNAL MAY ASK THE ICC FOR A FURTHER
EXTENSION,
IF WARRANTED
Source text for Eikon: ID:
Further company coverage: TCON.O
((reuters.briefs@thomsonreuters.com;))
Recent news on TRACON Pharmaceuticals
See all newsBrief: TRACON Pharmaceuticals Says ENVASARC Trial ORR Is 5%, Does Not Meet 11% Endpoint
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Files For Offering Of Common Stock, Pre-Funded Warrants